Redpoint Investment Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$1.85M Sell
30,076
-1,556
-5% -$98.1K 0.27% 87
2022
Q2
$1.96M Sell
31,632
-388
-1% -$24K 0.23% 99
2022
Q1
$1.9M Hold
32,020
0.19% 123
2021
Q4
$2.33M Sell
32,020
-1,607
-5% -$111K 0.18% 131
2021
Q3
$2.35M Sell
33,627
-419
-1% -$29.4K 0.2% 126
2021
Q2
$2.34M Hold
34,046
0.19% 131
2021
Q1
$2.2M Buy
34,046
+695
+2% +$44.8K 0.19% 134
2020
Q4
$1.94M Buy
33,351
+1,465
+5% +$88.4K 0.2% 128
2020
Q3
$2.02M Sell
31,886
-43,920
-58% -$3.05M 0.22% 108
2020
Q2
$5.83M Sell
75,806
-6,815
-8% -$522K 0.32% 70
2020
Q1
$6.18M Sell
82,621
-17,196
-17% -$1.19M 0.39% 62
2019
Q4
$6.49M Sell
99,817
-1,112
-1% -$72.4K 0.32% 76
2019
Q3
$6.4M Buy
100,929
+4,083
+4% +$267K 0.34% 65
2019
Q2
$6.54M Sell
96,846
-6,213
-6% -$409K 0.35% 62
2019
Q1
$6.7M Hold
103,059
0.34% 66
2018
Q4
$6.45M Sell
103,059
-1,021
-1% -$71.4K 0.38% 59
2018
Q3
$8.04M Sell
104,080
-6,032
-5% -$456K 0.41% 52
2018
Q2
$7.8M Sell
110,112
-5,507
-5% -$389K 0.42% 49
2018
Q1
$8.72M Buy
115,619
+1,153
+1% +$91.7K 0.48% 46
2017
Q4
$8.2M Buy
+114,466
New +$8.69M 0.45% 48

Other funds holding GILD

Redpoint Investment Management's GILD Position: Q3 2022 in Review

Redpoint Investment Management reduced its Gilead Sciences (GILD) stake by 4.9% in Q3 2022, selling an estimated $98.1K and leaving 30,076 shares worth $1.85M. The position accounts for 0.27% of the portfolio, ranked #87.

Redpoint Investment Management first reported a position in GILD in Q4 2017 and has held it in 20 quarters since. The position peaked at $8.72M in Q1 2018. 1,602 funds tracked by Wall St. Rank hold GILD as of Q3 2022.

  • Redpoint Investment Management held 30,076 shares of Gilead Sciences worth $1.85M as of Q3 2022.
  • Redpoint Investment Management sold 1,556 Gilead Sciences shares in Q3 2022, an estimated $98.1K.
  • Gilead Sciences made up 0.27% of Redpoint Investment Management's portfolio in Q3 2022, its #87 holding.
  • Redpoint Investment Management first reported a position in Gilead Sciences in Q4 2017 and has held it in 20 quarters since.
  • Redpoint Investment Management's Gilead Sciences position peaked at $8.72M in Q1 2018.
  • 1,602 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2022.

Based on Redpoint Investment Management's 13F filing for Q3 2022, filed 14 Oct 2022.